STOCK TITAN
  1. Home
  2. Sec-filings
  3. IVVD
  4. [Form 4] Invivyd, Inc. Insider Trading Activity

Invivyd (IVVD) HR chief logs RSU vesting and tax sell-to-cover sales

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Invivyd, Inc.’s Chief Human Resources Officer Julie Green reported RSU vesting and related share sales. On February 15, she acquired 99,000 shares of common stock at $0.00 per share through the conversion of restricted stock units, increasing her direct common stock holdings.

On February 17 and 18, Green sold a total of 40,627 common shares in open-market transactions at weighted average prices of $1.5396 and $1.5778 per share. Footnotes explain these were non-discretionary “sell-to-cover” trades under a Rule 10b5-1 plan to satisfy tax withholding on the RSU vesting. After these transactions, she directly held 107,717 common shares.

Positive

  • None.

Negative

  • None.
Insider Green Julie
Role Chief Human Resources Officer
Sold 40,627 shs ($63K)
Type Security Shares Price Value
Sale Common Stock 20,964 $1.5778 $33K
Sale Common Stock 19,663 $1.5396 $30K
Exercise Restricted Stock Units 99,000 $0.00 --
Exercise Common Stock 99,000 $0.00 --
Holdings After Transaction: Common Stock — 107,717 shares (Direct); Restricted Stock Units — 102,000 shares (Direct)
Footnotes (1)
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Green Julie
(Last) (First) (Middle)
C/O INVIVYD, INC.
209 CHURCH STREET
(Street)
NEW HAVEN CT 06510
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Human Resources Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/15/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/15/2026 M 99,000 A (1) 148,344 D
Common Stock 02/17/2026 S 19,663(2) D $1.5396(3) 128,681 D
Common Stock 02/18/2026 S 20,964(2) D $1.5778(4) 107,717 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 02/15/2026 M 99,000 (5) (5) Common Stock 99,000 $0.00 102,000 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
2. The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
5. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
/s/ Jill Andersen attorney-in-fact for Julie Green 02/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Invivyd (IVVD) executive Julie Green report?

Julie Green reported both RSU vesting and stock sales. She acquired 99,000 Invivyd common shares via restricted stock unit conversion, then sold 40,627 shares in open-market transactions to cover tax withholding obligations tied to that vesting under a pre-established Rule 10b5-1 plan.

How many Invivyd (IVVD) shares did Julie Green sell and at what prices?

Julie Green sold 40,627 Invivyd common shares. She sold 19,663 shares at a weighted average price of $1.5396 and 20,964 shares at a weighted average price of $1.5778, with individual trades occurring within stated price ranges on each day.

Were Julie Green’s Invivyd (IVVD) stock sales discretionary trades?

The sales were described as non-discretionary sell-to-cover trades. Footnotes state the transactions were executed under a Rule 10b5-1 trading plan to satisfy tax withholding obligations arising from vesting of a restricted stock unit award granted to Julie Green.

How many Invivyd (IVVD) shares does Julie Green own after these transactions?

After the reported transactions, Julie Green directly holds 107,717 shares. This figure reflects her common stock position following the RSU conversion of 99,000 shares and subsequent open-market sales totaling 40,627 shares executed to cover associated tax obligations.

What are the terms of Julie Green’s Invivyd (IVVD) RSU award?

The RSU award vests over eighteen months. One-third of the restricted stock units vest every six months following the February 15, 2025 grant date, contingent on Julie Green’s continuous service with Invivyd on each scheduled vesting date.

How are the reported Invivyd (IVVD) sale prices for Julie Green’s trades calculated?

The reported sale prices are weighted averages. Footnotes explain the shares were sold in multiple transactions within price ranges, and the Form 4 discloses a single weighted average price for each day, with detailed trade data available upon request.